Related Experiment Video
Updated: Apr 14, 2026

07:06
Surgical Technique for the Implantation of a Biomimetic Artificial Intervertebral Disc in a Goat Animal Model
Published on: October 10, 2025
750
Intervertebral Disc Tissue Engineering with Natural Extracellular Matrix-Derived Biphasic Composite Scaffolds
Baoshan Xu1, Haiwei Xu2, Yaohong Wu2
1Department of minimally invasive spine surgery, Tianjin Hospital, 406 Jie Fang Nan Road, Hexi District, Tianjin, 300211, People's Republic of China.
Plos One
|April 21, 2015
Summary
Researchers developed a novel biphasic scaffold using pig bone matrix gelatin and acellular cartilage ECM for intervertebral disc (IVD) tissue engineering. This biomimetic scaffold successfully supported cell growth and formed IVD-like tissue in vivo, showing promise for treating degenerative disc diseases.
Area of Science:
- Biomaterials Science
- Regenerative Medicine
- Tissue Engineering
Background:
- Degenerative disc diseases lack ideal tissue engineering scaffolds.
- Intervertebral disc (IVD) tissue engineering offers a therapeutic alternative.
- Novel biomimetic scaffolds are crucial for successful IVD regeneration.
Purpose of the Study:
- To fabricate a novel biomimetic biphasic scaffold for IVD tissue engineering.
- To evaluate the feasibility of developing tissue-engineered IVD in vitro and in vivo.
- To assess the potential of bone matrix gelatin and acellular cartilage ECM for IVD repair.
Main Methods:
- Developed an integrated biphasic scaffold using freeze-drying and cross-linking of pig bone matrix gelatin (BMG) for annulus fibrosus (AF) and pig acellular cartilage ECM (ACECM) for nucleus pulposus (NP).
- Characterized scaffold microstructure (pore size) using SEM and confirmed absence of residual cells.
- Seeded PKH26-labeled AF and NP cells, cultured in vitro, and implanted constructs subcutaneously into nude mice for 6 weeks.
Main Results:
- Scaffold exhibited interconnected porous microstructure (AF: 401.4 ± 13.1 μm, NP: 231.6 ± 57.2 μm).
- In vitro studies confirmed cell adhesion and viability.
- In vivo implantation resulted in the formation of IVD-like tissue, with cells originating from labeled cells tracked via fluorescence imaging.
Conclusions:
- Demonstrated the feasibility of developing a tissue-engineered IVD in vivo using a BMG- and ACECM-derived biphasic scaffold.
- PKH26 fluorescent labeling and in vivo imaging are effective for tracking cells and analyzing cell-scaffold constructs.
- This approach holds promise for treating degenerative disc diseases.

